Fresenius SE & Co. KGaA (GB:0OO9)
LSE:0OO9
UK Market
GB:0OO9Fresenius SE & Co. KGaA
€45.41
-€0.333 (-0.73%)

Fresenius SE & Co. KGaA Stock Analysis & Ratings

Fresenius SE & Co. KGaA Stock Analysis Overview

Smart Score
N/A
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
CONSENSUS
Moderate Buy
Average Price Target : €49.40
SENTIMENT
N/A
Currently Not Enough Data Available

HEDGE FUND ACTIVITY

TREND
N/A
Currently Not Enough Data Available
TREND
N/A
Currently Not Enough Data Available

TIPRANKS INVESTORS

SENTIMENT
N/A
Currently Not Enough Data Available
LAST 7 DAYS
N/A
Currently Not Enough Data Available

TECHNICALS

SMA
Positive
20 days / 200 days
MOMENTUM
2.55%
12 Months Change

FUNDAMENTALS

RETURN ON EQUITY
N/A
Trailing 12 Months
ASSET GROWTH
N/A
Trailing 12 Months
This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.

Stock Chart

GB:0OO9

GB:0OO9 Stock Stats

Previous Close€45.74
Open€45.55
Bid0 x 0
Ask0 x 0
Today’s Range€45.03 - €45.6525
52-Week Range€24.01 - €51.54
Volume703.46K
Average Volume469.83K
Market Cap€25.32B
Beta1.32
P/E Ratio15.2
EPS3.02
Earnings DateJul 30, 2021
Dividend & Yield0.84 (1.92%)
Ex-Dividend DateMay 25, 2021

Company Description

Fresenius SE & Co. KGaA

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care, which accounted for 49% of consolidated revenue in 2019. The Kabi segment (19% of revenue) manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. At 26% of revenue, the Helios segment operates private hospitals in Germany, Spain, and Latin America. At 6% of revenue, Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Sector
Healthcare
Industry
Healthcare Providers & Services
CEO
N/A
Employees
310,842
Address
Else-Kroener-Strasse 1, Bad Homburg v.d.H, 61352, DE

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

GB:0OO9 FAQ

What was Fresenius SE & Co. KGaA’s price range in the past 12 months?
Fresenius SE & Co. KGaA lowest stock price was €24.01 and its highest was €51.54 in the past 12 months.
    What is Fresenius SE & Co. KGaA’s market cap?
    Fresenius SE & Co. KGaA’s market cap is €25.32B.
      What is Fresenius SE & Co. KGaA’s price target?
      The average price target for Fresenius SE & Co. KGaA is €49.40. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is €57.00 ,the lowest forecast is €40.00. The average price target represents 8.80% Increase from the current price of €45.405.
        What do analysts say about Fresenius SE & Co. KGaA?
        Fresenius SE & Co. KGaA’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.
          When is Fresenius SE & Co. KGaA’s upcoming earnings report date?
          Fresenius SE & Co. KGaA’s upcoming earnings report date is Jul 30, 2021 which is in 2 days.
            How were Fresenius SE & Co. KGaA’s earnings last quarter?
            Fresenius SE & Co. KGaA released its earnings results on May 06, 2021. The company reported €0.78 earnings per share for the quarter, beating the consensus estimate of €0.775 by €0.005.
              Is Fresenius SE & Co. KGaA overvalued?
              According to Wall Street analysts Fresenius SE & Co. KGaA’s price is currently Undervalued.
                Does Fresenius SE & Co. KGaA pay dividends?
                Fresenius SE & Co. KGaA pays a Notavailable dividend of €0.88 which represents an annual dividend yield of 1.92%. Fresenius SE & Co. KGaA’s last Notavailable dividend payment was on May 27, 2021. Fresenius SE & Co. KGaA’s upcoming ex-dividend date is May 25, 2021
                  What is Fresenius SE & Co. KGaA’s EPS estimate?
                  Fresenius SE & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
                  How many shares outstanding does Fresenius SE & Co. KGaA have?
                  Fresenius SE & Co. KGaA has 557,540,000 shares outstanding.
                    What happened to Fresenius SE & Co. KGaA’s price movement after its last earnings report?
                    Fresenius SE & Co. KGaA reported an EPS of €0.78 in its last earnings report, beating expectations of €0.775. Following the earnings report the stock price went up 0.69%.
                      Which hedge fund is a major shareholder of Fresenius SE & Co. KGaA?
                      Currently, no hedge funds are holding shares in GB:0OO9

                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis